@TCELL HIMOTHY

I’M HIM

[Vaxart @Vaxart]

“Passive transfer of antibodies from mothers to infants via breast milk is an innovative approach to potentially improve infection resistance in infants,” said $VXRT CMO Dr. Cummings. https://t.co/7MYdZlgjGE #pillthatmovestheneedle #norovirus #globalhealth

[Brook Jackson 💜 @IamBrookJackson]

🚨Well, hells bells! As had been previously signaled in the clinical trials—here is confirmation of a statistically significant association between Pfizer’s RSV vaccine & preterm births!

Beware mommas! 🙏🏻
@ChildrensHD
https://t.co/XRLfhC9UNG

[CSIMarket.com @CSIMarket]

Promising Advancements in Norovirus Vaccine Development for Lactating Mothers: Antibody Elevation in Breast Milk: $VXRT for https://t.co/savSNU2v19 :In recent developments in vaccine research, Vaxart has announced… https://t.co/ELFUfqawxb #VXRT #VaxartInc #ClinicalStudy #News

[Vaxart @Vaxart]

$VXRT CMO Dr. Cummings: “This is an important step forward as we drive toward a vaccine candidate that may make it possible for mothers to protect their children against this highly contagious – and potentially lethal – virus.” https://t.co/7MYdZlgjGE #pillthatmovestheneedle

[@XRP_Tim @SPOT_XRP]

@BillGates @melindagates Your funding is critical for saving countless lives please continue to support @Vaxart with as much power as possible!! 🙏🙏🙏

[Vaxart @Vaxart]

$VXRT today said it has completed the topline analysis for the Phase 1 clinical trial evaluating its oral pill bivalent norovirus vaccine candidate in lactating mothers. View the full release here: https://t.co/7MYdZlgjGE. #pillthatmovestheneedle #norovirus

[AccuWeather @accuweather]

A massive tornado tore through Elkhorn, Nebraska, today, causing significant damage.

[@TCELL HIMOTHY @X2dot0]

@Vaxart We are in the 2nd quarter, what day is the FDA meeting?

[Vaxart @Vaxart]

$VXRT CSO Dr. Tucker: "Going forward, we plan to meet with the FDA during the second quarter of 2024 to discuss our data on potential correlates, a Phase 2b dose confirmation study and potentially a GII.4 challenge study." https://t.co/to5Z3sBBeO #pillthatmovestheneedle

[Vaxart @Vaxart]

$VXRT currently expects to announce topline results from the Phase 1 trial of its oral bivalent norovirus vaccine candidate in mid-2024, CSO Dr. Sean Tucker notes. https://t.co/O08ZBadjKM #pillthatmovestheneedle #norovirus #publichealth

[greg @greg16676935420]

The sunset is beautiful tonight

[@TCELL HIMOTHY @X2dot0]

@greg16676935420 Cloudy here

[@TCELL HIMOTHY @X2dot0]

@elonmusk Flip the script and mass produce these all EV

[Vaxart @Vaxart]

$VXRT Chair Dr. Finney explains that new CEO Steve Lo brings a wealth of biopharma experience to Vaxart, with more than 25 years in healthcare, biotech and pharmaceuticals. https://t.co/810e9M5UHM #pillthatmovestheneedle #CEO #vaccines #globalhealth

[@XRP_Tim @SPOT_XRP]

@Vaxart We need official PR’s for FDA meeting and COP!!

[@TCELL HIMOTHY @X2dot0]

@NBCNews

[@TCELL HIMOTHY @X2dot0]

@Chris_1791 @DailyCaller

[@TCELL HIMOTHY @X2dot0]

@Vaxart https://t.co/qyAbt1LuP9